BioStem Technologies, Inc. (BSEM) Presents at Morgan Stanley 23rd Annual Global Healthcare
Seeking Alphaยท2025-09-10 22:15
Company Overview - BioStem Technologies is a profitable med tech company focused on advanced wound care [2] - The company's core technology is BioREtain, which processes placental-based tissue allografts [2] Market Potential - The target patient population includes approximately 7 million Medicare beneficiaries [3] - The total market for advanced wound care is estimated to be around $11.3 billion [3]